Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy's makes senior changes as US generics head exits

UmangVohra will be replaced by Alok Sonig

Dr Reddy's Umang VohraDr Reddy's has appointed Alok Sonig to be its new head of North America generics to take over from Umang Vohra (pictured).

Vohra is leaving the Indian generics-focused company after nearly three years as its executive VP and head North America Generics.

In total he spent 13 years with the firm, which he joined in 2002 from Pepsico-India, where he was financial planning manager.

Vohra's replacement at Dr Reddy's is the company's head of India generics Alok Sonig who, prior to joining the firm, served at Bristol-Myers Squibb, where he spent three years as managing director of BMS India.

To fill Sonig's vacant role Dr Reddy's has handed MV Ramana, currently executive vice president - emerging markets, additional responsibilities with a move to executive vice president and head branded markets (India and emerging countries).

1st September 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics